Stony Brook University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Stony Brook University sits in the top decile of US sponsors by registered trial count (#213 of 15,742 sponsors by registered trial count).

127 total trials 24 currently recruiting 81 completed top decile by trial count

Stony Brook University: 127 sponsored US clinical trials, 24 recruiting.

Stony Brook University sponsors 127 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 81 completed. 22 of these trials are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 3 trials.

Top-decile sponsor footprint

Stony Brook University ranks in the top decile of sponsors by registered trial count (#213 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

81 of 95 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

127 total, page 2 of 3

COMPLETED Phase 1

Phase I Trial HIPEC With Nal-irinotecan

NCT04088786
COMPLETED NA

Evaluating the Single-Session Consultation Service at the Krasner Psychological Center and Putnam

NCT04069832
COMPLETED NA

Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction

NCT04122703
TERMINATED Phase 2

Controlling Rapid Atrial Fibrillation With Dexmedetomidine

NCT04042727
TERMINATED Phase 2

Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease

NCT03971617
COMPLETED NA

Hydrogen Water Treatment for Chronic Fatigue Syndrome

NCT05013606
COMPLETED

Next Generation Sequencing Detection of Lyme Disease

NCT03505879
TERMINATED NA

Condensed Percutaneous Tibial Nerve Stimulation (PTNS) Protocol

NCT03559946
COMPLETED NA

Activating and Identifying Neural Responses to Social Rejection: a Combined tDCS and fMRI Study

NCT02739789
COMPLETED NA

Asynchronous Techniques for the Delivery of Empirically Supported Psychotherapies

NCT05122429
COMPLETED Phase 2

Flu Vaccine Response in Patients on Biologic Therapies

NCT03277703
COMPLETED Phase 4

Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy

NCT03435003
COMPLETED Phase 2

Neuroprotection in Acute Ischemic Stroke

NCT03320018
COMPLETED Phase 1

Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)

NCT03137082
COMPLETED Early Phase 1

Fecal Microbial Transplantation in Patients With Crohn's Disease

NCT03267238
COMPLETED Phase 4

General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial

NCT03034096
TERMINATED NA

A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT03020797
COMPLETED Phase 4

VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?

NCT02918851
TERMINATED NA

Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits

NCT03034109
COMPLETED Phase 4

Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

NCT02812186
COMPLETED Phase 4

Quality of Recovery After Reversal With Neostigmine or Sugammadex.

NCT02909439
TERMINATED Phase 2

Percocet vs. Bupivicaine for Toothaches in the ED

NCT02862691
COMPLETED

Endogenous Opioid Mechanisms for Rejection Sensitivity

NCT02189785
COMPLETED

The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study

NCT02801643
TERMINATED NA

Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy

NCT02915484
COMPLETED NA

Acupressure in Hospitalized Patients

NCT02762435
COMPLETED NA

Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS

NCT02606604
TERMINATED Phase 2

Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders

NCT02487082
COMPLETED Phase 4

Advancing Personalized Antidepressant Treatment Using PET/MRI

NCT02623205
COMPLETED NA

Dietary Sodium Intake and Outcomes in Heart Failure

NCT02467296
COMPLETED

Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery

NCT02275507
COMPLETED NA

Health Outcomes After Locomotor Training in Spinal Cord Injury

NCT02201173
COMPLETED NA

Assessment of the Effects of Different Implant Abutment Occluding Materials on Dental Implant Health Parameters and Microbiology

NCT02625597
COMPLETED Early Phase 1

Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis

NCT03268213
COMPLETED NA

Stress Management Program for World Trade Center (WTC) Responders

NCT02457780
COMPLETED NA

Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya

NCT02141022
COMPLETED

Effects of Bracing on Knee Osteoarthritis (OA)

NCT01886144
COMPLETED Phase 1

Brain Dynamics of Oxytocin

NCT01834261
COMPLETED Phase 2

NSAID Effects on Clinical and Imaging Breast Biomarkers

NCT01761877
COMPLETED Phase 1

Effect of Socket Wall Height With Vacuum Suspension for Above Knee Amputees

NCT01559909
COMPLETED NA

Enhanced Smoking Cessation Intervention for Smokers Exposed to the World Trade Center (WTC) Disaster

NCT02538601
COMPLETED NA

PET and MRI Brain Imaging of Bipolar Disorder

NCT01880957
COMPLETED NA

Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis

NCT01986686
COMPLETED NA

Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)

NCT01419301
COMPLETED

Urinary 8-isoprostane is Elevated in Acute Childhood Asthma

NCT01472471
COMPLETED Phase 4

Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction

NCT01244698
COMPLETED Phase 1

Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA

NCT01833273
COMPLETED NA

Trial With Deltex Cardio in Elective Bowel Resection Patients

NCT01244685
COMPLETED

Laparascopic Assisted Colonoscopic Polypectomy

NCT01986699
COMPLETED NA

Trans-anal Hemorrhoidal Dearterialization (THD) vs. Hemorrhoidectomy

NCT01244672
← Previous Page 2 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 18
Phase 2 15
Phase 3 5
Phase 4 17

Therapeutic Areas

Healthy 3
Major Depressive Disorder (MDD) 2
Anxiety 2
Major Depressive Disorder 2
Dental Implant Failure Nos 1
1 Fluid Management 1
Brain Dynamics in Healthy Adults 1
Tracheobronchitis 1
Neuroinflammation 1
Arthroplasty, Replacement, Hip 1

What is open in the Stony Brook University pipeline

24 recruiting of 127 indexed (19% open); 81 completed (64%).

Phase mix: 22 late (III/IV) vs 33 early (I/II) (balanced across stages).

Top condition: Healthy (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Stony Brook University: open-pipeline peers nationwide

Peers matched on 127 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Stony Brook University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 10%20%30%40%50% Total trials Recruiting share Stony Brook UniversityJazz PharmaceuticalsThe Methodist Hospital Research InstituteUniversity of Illinois at Urbana-ChampaignMethodist Health SystemIpsenSpaulding Rehabilitation HospitalMedical University of South CarolinaJonsson Comprehensive Cancer Center
Stony Brook University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Stony Brook University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 127 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Stony Brook University page

127 registered trials is a research-attention snapshot, not an endorsement of Stony Brook University or any single study.

  • 24 of Stony Brook University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition Stony Brook University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Stony Brook University pipeline card: 127 registered trials from official public datasets.Report a data error.